These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 25607842)

  • 1. MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4.
    Walsh JT; Hendrix S; Boato F; Smirnov I; Zheng J; Lukens JR; Gadani S; Hechler D; Gölz G; Rosenberger K; Kammertöns T; Vogt J; Vogelaar C; Siffrin V; Radjavi A; Fernandez-Castaneda A; Gaultier A; Gold R; Kanneganti TD; Nitsch R; Zipp F; Kipnis J
    J Clin Invest; 2015 Feb; 125(2):699-714. PubMed ID: 25607842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role reversal: infiltrating T cells protect the brain.
    Steinman L
    J Clin Invest; 2015 Feb; 125(2):493-4. PubMed ID: 25607835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal development and activation but altered cytokine production of Fyn-deficient CD4+ T cells.
    Mamchak AA; Sullivan BM; Hou B; Lee LM; Gilden JK; Krummel MF; Locksley RM; DeFranco AL
    J Immunol; 2008 Oct; 181(8):5374-85. PubMed ID: 18832694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL.
    Matte-Martone C; Liu J; Jain D; McNiff J; Shlomchik WD
    Blood; 2008 Apr; 111(7):3884-92. PubMed ID: 18223170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional evidence for TCR-intrinsic specificity for MHCII.
    Parrish HL; Deshpande NR; Vasic J; Kuhns MS
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3000-5. PubMed ID: 26831112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-Cell-Specific Loss of the PI-3-Kinase p110α Catalytic Subunit Results in Enhanced Cytokine Production and Antitumor Response.
    Aragoneses-Fenoll L; Ojeda G; Montes-Casado M; Acosta-Ampudia Y; Dianzani U; Portolés P; Rojo JM
    Front Immunol; 2018; 9():332. PubMed ID: 29535720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myd88 Initiates Early Innate Immune Responses and Promotes CD4 T Cells during Coronavirus Encephalomyelitis.
    Butchi N; Kapil P; Puntambekar S; Stohlman SA; Hinton DR; Bergmann CC
    J Virol; 2015 Sep; 89(18):9299-312. PubMed ID: 26136579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RasGRP1 transmits prodifferentiation TCR signaling that is crucial for CD4 T cell development.
    Priatel JJ; Chen X; Dhanji S; Abraham N; Teh HS
    J Immunol; 2006 Aug; 177(3):1470-80. PubMed ID: 16849453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trogocytosis results in sustained intracellular signaling in CD4(+) T cells.
    Osborne DG; Wetzel SA
    J Immunol; 2012 Nov; 189(10):4728-39. PubMed ID: 23066151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy.
    Jones TB; Basso DM; Sodhi A; Pan JZ; Hart RP; MacCallum RC; Lee S; Whitacre CC; Popovich PG
    J Neurosci; 2002 Apr; 22(7):2690-700. PubMed ID: 11923434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4
    Lin L; Chen Z; Dai F; Wei JJ; Tang XY; Sun GB
    Auris Nasus Larynx; 2019 Aug; 46(4):533-541. PubMed ID: 30554982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxoplasma gondii dense granule protein GRA24 drives MyD88-independent p38 MAPK activation, IL-12 production and induction of protective immunity.
    Mercer HL; Snyder LM; Doherty CM; Fox BA; Bzik DJ; Denkers EY
    PLoS Pathog; 2020 May; 16(5):e1008572. PubMed ID: 32413093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Casitas B-lineage lymphoma b inhibits antigen recognition and slows cell cycle progression at late times during CD4+ T cell clonal expansion.
    Zhang R; Zhang N; Mueller DL
    J Immunol; 2008 Oct; 181(8):5331-9. PubMed ID: 18832689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of Multiple Hybrid Insulin Peptides by a Single Highly Diabetogenic T-Cell Receptor.
    Parras D; Solé P; Delong T; Santamaría P; Serra P
    Front Immunol; 2021; 12():737428. PubMed ID: 34527002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helminth-conditioned dendritic cells prime CD4+ T cells to IL-4 production in vivo.
    Connor LM; Tang SC; Camberis M; Le Gros G; Ronchese F
    J Immunol; 2014 Sep; 193(6):2709-17. PubMed ID: 25108019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role for Rsk2 in T-lymphocyte activation.
    Lin JX; Spolski R; Leonard WJ
    Blood; 2008 Jan; 111(2):525-33. PubMed ID: 17938253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A transgenic TCR directs the development of IL-4+ and PLZF+ innate CD4 T cells.
    Zhu L; Qiao Y; Choi ES; Das J; Sant'angelo DB; Chang CH
    J Immunol; 2013 Jul; 191(2):737-44. PubMed ID: 23776174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis.
    Aragoneses-Fenoll L; Montes-Casado M; Ojeda G; Acosta YY; Herranz J; Martínez S; Blanco-Aparicio C; Criado G; Pastor J; Dianzani U; Portolés P; Rojo JM
    Biochem Pharmacol; 2016 Apr; 106():56-69. PubMed ID: 26883061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of TCR-induced extracellular signal-regulated kinase activation in the regulation of early IL-4 expression in naive CD4+ T cells.
    Jorritsma PJ; Brogdon JL; Bottomly K
    J Immunol; 2003 Mar; 170(5):2427-34. PubMed ID: 12594266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation.
    Casares S; Zong CS; Radu DL; Miller A; Bona CA; Brumeanu TD
    J Exp Med; 1999 Aug; 190(4):543-53. PubMed ID: 10449525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.